Каталог · ЕАЭС
Клинические исследования и проекты
Онкология · F.Hoffmann-La Roche Ltd, Basel · найдено 2
2 исследования
Статус неизвестен
Фаза IV
Беларусь
ВЕМУРАФЕНИБ
An Open-Label, Extension (Rollover) Study of Vemurafenib in Patients With BRAF V600 Mutation-Positive Malignancies Previously Enrolled in an Antecedent Vemurafenib Protocol
Завершено
Фаза I
Беларусь
ВЕМУРАФЕНИБ
A Phase I, Open-Label, Multicenter, 3-Period, Fixed-Sequence Study To Investigate The Effect Of Vemurafenib On The Pharmacokinetics Of A Single Dose Of Digoxin In Patients With BRAFV600 Mutation-Positive Metastatic Malignancy